Adam Jakus

CEO
BioThera3 Advising & Consulting

2025

16:15

Main Stage

Living Layers – R&D behind Biofabrication

Adam Jakus
BioThera3 Advising & Consulting
Maurizio Gullo
FHNW School of Life Sciences
Laura Elomaa
Cellbricks
Tiziano Serra
AO Foundation
Andrea Barbero
University of Basel
Valentina Basoli
University of Basel

2024

Adam Jakus

Dr. Adam Jakus, Ph.D. serves as the founding-CEO of BioThera3 Advising & Consulting, the COO of PRO Therapeutics. Prior to his current role, Dr. Jakus founded and served as CTO of Dimension Inx Corp, where he commercialized the first FDA cleared 3D-printed, regenerative product on the US market. He is champion of the bioprinting and biofabrication industries, providing support, guidance, and advice to new founders and young companies, while contributing to bioprinting standards development and industrialization as well as being the primary author and inventor on dozens of research publications, book chapters, and patents related to advanced materials and bioprinting.

25th of June 2025

MGA Medical Pre-Events

11:30

Consultation on 3D Printing in Pharmaceutics: Best practices and technologies (open)

15:00

MGA Medical Strategic Committee Meeting (closed)

For registration, please reach out to medical@mga-net.com

Please enable JavaScript in your browser to complete this form.
Name